The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study

Abstract Background The MORDOR study, a cluster randomized clinical trial, showed that single-dose azithromycin (20 mg/kg) administered biannually for 2 years to preschool children reduced mortality; a study was conducted to determine its effect on clinical symptomatic episodes of malaria as a poten...

Full description

Bibliographic Details
Main Authors: Evan M. Bloch, Beatriz Munoz, Zakayo Mrango, Jerusha Weaver, Leonard E. G. Mboera, Tom M. Lietman, David J. Sullivan, Sheila K. West
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Malaria Journal
Subjects:
Malaria
Clinical trial
Azithromycin
Child mortality
Tanzania
Online Access:http://link.springer.com/article/10.1186/s12936-019-2914-8

Internet

http://link.springer.com/article/10.1186/s12936-019-2914-8

Similar Items